1. Sugano, Y., Mizuta, M., Takao, S., et al., Optimization of the fractionated irradiation scheme considering physical doses totumorand organ at risk based on dose-volume histograms, Med. Phys., 2015, vol. 42, no. 11, pp. 6203–6210. https://doi.org/10.1118/1.4931969
2. King, M., Joseph, S., Albert, A., et al., Use of amifostine for cytoprotection during radiation therapy: a review, Oncology, 2020, vol. 98, pp. 61–80. https://doi.org/10.1159/000502979
3. Vasin, M.V., Ushakov, I.B., and Suvorov, N.N., Radioprotective efficiency of indralin under local skin γ-irradiation, Radiats. Biol., Radioekol., 1998, vol. 38, no. 1, pp. 42–54.
4. Vasin, M.V., Ushakov, I.B., Semenova, L.A., et al., Radioprotective efficiency of α-adrenomimetics with under local skin γ-irradiation, Radiats. Biol., Radioekol., 1999, vol. 39, nos. 2–3, рр. 249–253.
5. Vasin, M.V., Ushakov, I.B., Kovtun, V.Yu., and Komarova, S.N., Comparative efficacy of the antioxidant melatonin and the radioprotectors indralin and mezaton in local radiation injuries, Radiats. Biol., Radioekol., 2004, vol. 44, no. 1, pp. 68–71.